Welcome

    Dear Attendees, 


 Referring to the postponement of Congress "Diagnostic Histopathology and Molecular Pathology of Gynecological Tumors" due to the recent health emergency, on behalf of Prof. Dei Tos we inform you that the Congress will be postponed to 2021 in virtual mode


 We hope You will be able again to take part to Diagnostic Histopathology and Molecular Pathology of Gynecological Tumors with the new format.


We will inform You as soon as possible about the new scheduled dates.


Sure of your understanding, we thank you for the attention.


Kind regards


The Secretariat and CME Provider
Doc Congress Srl  

COURSE DIRECTOR 

Angelo Paolo Dei Tos
Professor of Pathology,
Director of Pathology Department of Medicine,
University of Padua School of Medicine, Padova (Italy)

SCIENTIFIC COMMITTEE

Prof. Matteo Fassan
Associate Professor of Pathology University of Padua School of Medicine, Padova (Italy)

Marta Sbaraglia
Pathology Department of Medicine, University of Padua School of Medicine, Padova (Italy)

SPEAKERS

Marisa Rose Nucci 
Professor of Pathology Harvard Medical School; Director, Division of Women’s and Perinatal Pathology, Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts USA

Brooke Howitt 
Assistant Professor of Pathology at the Stanford University Medical Center Department of Pathology Stanford, California Usa

IDENTIFIED PROFESSIONAL PRACTICE GAPS:

Increasing complexity of gynecological oncologic pathology related to the need of precision medicine

Increasing complexity of gynecological oncologic pathology related to extreme segmentation of tumor entities

Necessity to integrate morphology with new molecular findings

Necessity to provide medical oncologists with reliable prognostic and predictive biomarkers

learning objectives
After successful completion of the educational activities, participants should be able to:

Recognize the diagnostic challenges of major subsets of oncologic gynecological pathology.

Correlate morphology with immunophenotypical and molecular findings.

Interpret morphologic findings in the appropriate clinical context.

Answer the need for more robust prognostic and predictive biomarkers.

Understand future research directions and potentials for changing the clinicopathologic landscape in specific fields of gynecological oncologic pathology.  

PATRONAGE

ON REQUEST

University of Padua

SIAPEC-IAP

ERN - EURACAN